Malaria Vaccines Market
1 Study Coverage
1.1 Malaria Vaccines Product Introduction
1.2 Global Malaria Vaccines Outlook 2017 VS 2022 VS 2028
1.2.1 Global Malaria Vaccines Sales in US$ Million for the Year 2017-2028
1.2.2 Global Malaria Vaccines Sales in Volume for the Year 2017-2028
1.3 United States Malaria Vaccines Outlook 2017 VS 2022 VS 2028
1.3.1 United States Malaria Vaccines Sales in US$ Million for the Year 2017-2028
1.3.2 United States Malaria Vaccines Sales in Volume for the Year 2017-2028
1.4 Malaria Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Malaria Vaccines in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Malaria Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Malaria Vaccines Market Dynamics
1.5.1 Malaria Vaccines Industry Trends
1.5.2 Malaria Vaccines Market Drivers
1.5.3 Malaria Vaccines Market Challenges
1.5.4 Malaria Vaccines Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Malaria Vaccines Market Segment by Type
2.1.1 Pre-Erythrocytic Vaccine
2.1.2 Erythrocytic Vaccine
2.1.3 Multi-antigen Vaccine
2.2 Global Malaria Vaccines Market Size by Type
2.2.1 Global Malaria Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Malaria Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Malaria Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Malaria Vaccines Market Size by Type
2.3.1 United States Malaria Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Malaria Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Malaria Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Malaria Vaccines Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Community Centers
3.2 Global Malaria Vaccines Market Size by Application
3.2.1 Global Malaria Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Malaria Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Malaria Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Malaria Vaccines Market Size by Application
3.3.1 United States Malaria Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Malaria Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Malaria Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Malaria Vaccines Competitor Landscape by Company
4.1 Global Malaria Vaccines Market Size by Company
4.1.1 Top Global Malaria Vaccines Manufacturers Ranked by Revenue (2021)
4.1.2 Global Malaria Vaccines Revenue by Manufacturer (2017-2022)
4.1.3 Global Malaria Vaccines Sales by Manufacturer (2017-2022)
4.1.4 Global Malaria Vaccines Price by Manufacturer (2017-2022)
4.2 Global Malaria Vaccines Concentration Ratio (CR)
4.2.1 Malaria Vaccines Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Malaria Vaccines in 2021
4.2.3 Global Malaria Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Malaria Vaccines Manufacturing Base Distribution, Product Type
4.3.1 Global Malaria Vaccines Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Malaria Vaccines Product Type
4.3.3 Date of International Manufacturers Enter into Malaria Vaccines Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Malaria Vaccines Market Size by Company
4.5.1 Top Malaria Vaccines Players in United States, Ranked by Revenue (2021)
4.5.2 United States Malaria Vaccines Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Malaria Vaccines Sales by Players (2020, 2021 & 2022)
5 Global Malaria Vaccines Market Size by Region
5.1 Global Malaria Vaccines Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Malaria Vaccines Market Size in Volume by Region (2017-2028)
5.2.1 Global Malaria Vaccines Sales in Volume by Region: 2017-2022
5.2.2 Global Malaria Vaccines Sales in Volume Forecast by Region (2023-2028)
5.3 Global Malaria Vaccines Market Size in Value by Region (2017-2028)
5.3.1 Global Malaria Vaccines Sales in Value by Region: 2017-2022
5.3.2 Global Malaria Vaccines Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Malaria Vaccines Market Size YoY Growth 2017-2028
6.1.2 North America Malaria Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Malaria Vaccines Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Malaria Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Malaria Vaccines Market Size YoY Growth 2017-2028
6.3.2 Europe Malaria Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Malaria Vaccines Market Size YoY Growth 2017-2028
6.4.2 Latin America Malaria Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Malaria Vaccines Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Malaria Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 GlaxoSmithKline Plc
7.1.1 GlaxoSmithKline Plc Corporation Information
7.1.2 GlaxoSmithKline Plc Description and Business Overview
7.1.3 GlaxoSmithKline Plc Malaria Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.1.4 GlaxoSmithKline Plc Malaria Vaccines Products Offered
7.1.5 GlaxoSmithKline Plc Recent Development
7.2 Sanaria Inc
7.2.1 Sanaria Inc Corporation Information
7.2.2 Sanaria Inc Description and Business Overview
7.2.3 Sanaria Inc Malaria Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Sanaria Inc Malaria Vaccines Products Offered
7.2.5 Sanaria Inc Recent Development
7.3 Nobelpharma Co
7.3.1 Nobelpharma Co Corporation Information
7.3.2 Nobelpharma Co Description and Business Overview
7.3.3 Nobelpharma Co Malaria Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Nobelpharma Co Malaria Vaccines Products Offered
7.3.5 Nobelpharma Co Recent Development
7.4 Sumaya Biotech
7.4.1 Sumaya Biotech Corporation Information
7.4.2 Sumaya Biotech Description and Business Overview
7.4.3 Sumaya Biotech Malaria Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Sumaya Biotech Malaria Vaccines Products Offered
7.4.5 Sumaya Biotech Recent Development
7.5 GenVec
7.5.1 GenVec Corporation Information
7.5.2 GenVec Description and Business Overview
7.5.3 GenVec Malaria Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.5.4 GenVec Malaria Vaccines Products Offered
7.5.5 GenVec Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Malaria Vaccines Industry Chain Analysis
8.2 Malaria Vaccines Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Malaria Vaccines Distributors
8.3 Malaria Vaccines Production Mode & Process
8.4 Malaria Vaccines Sales and Marketing
8.4.1 Malaria Vaccines Sales Channels
8.4.2 Malaria Vaccines Distributors
8.5 Malaria Vaccines Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Malaria Vaccines CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Malaria Vaccines Market Trends
Table 3. Malaria Vaccines Market Drivers
Table 4. Malaria Vaccines Market Challenges
Table 5. Malaria Vaccines Market Restraints
Table 6. Global Malaria Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Malaria Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Malaria Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Malaria Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Malaria Vaccines Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Malaria Vaccines Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Malaria Vaccines Revenue Share by Manufacturer, 2017-2022
Table 13. Global Malaria Vaccines Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Malaria Vaccines Sales Share by Manufacturer, 2017-2022
Table 15. Global Malaria Vaccines Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Malaria Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Malaria Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Malaria Vaccines as of 2021)
Table 18. Top Players of Malaria Vaccines in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Malaria Vaccines Product Type
Table 20. Date of International Manufacturers Enter into Malaria Vaccines Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Malaria Vaccines Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Malaria Vaccines Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Malaria Vaccines Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Malaria Vaccines Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Malaria Vaccines Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Malaria Vaccines Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Malaria Vaccines Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Malaria Vaccines Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Malaria Vaccines Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Malaria Vaccines Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Malaria Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Malaria Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Malaria Vaccines Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Malaria Vaccines Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Malaria Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Malaria Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Malaria Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Malaria Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Malaria Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Malaria Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. GlaxoSmithKline Plc Corporation Information
Table 43. GlaxoSmithKline Plc Description and Business Overview
Table 44. GlaxoSmithKline Plc Malaria Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. GlaxoSmithKline Plc Malaria Vaccines Product
Table 46. GlaxoSmithKline Plc Recent Development
Table 47. Sanaria Inc Corporation Information
Table 48. Sanaria Inc Description and Business Overview
Table 49. Sanaria Inc Malaria Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Sanaria Inc Product
Table 51. Sanaria Inc Recent Development
Table 52. Nobelpharma Co Corporation Information
Table 53. Nobelpharma Co Description and Business Overview
Table 54. Nobelpharma Co Malaria Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Nobelpharma Co Product
Table 56. Nobelpharma Co Recent Development
Table 57. Sumaya Biotech Corporation Information
Table 58. Sumaya Biotech Description and Business Overview
Table 59. Sumaya Biotech Malaria Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Sumaya Biotech Product
Table 61. Sumaya Biotech Recent Development
Table 62. GenVec Corporation Information
Table 63. GenVec Description and Business Overview
Table 64. GenVec Malaria Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. GenVec Product
Table 66. GenVec Recent Development
Table 67. Key Raw Materials Lists
Table 68. Raw Materials Key Suppliers Lists
Table 69. Malaria Vaccines Customers List
Table 70. Malaria Vaccines Distributors List
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Malaria Vaccines Product Picture
Figure 2. Global Malaria Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Malaria Vaccines Market Size 2017-2028 (US$ Million)
Figure 4. Global Malaria Vaccines Sales 2017-2028 (K Units)
Figure 5. United States Malaria Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Malaria Vaccines Market Size 2017-2028 (US$ Million)
Figure 7. United States Malaria Vaccines Sales 2017-2028 (K Units)
Figure 8. United States Malaria Vaccines Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Malaria Vaccines Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Malaria Vaccines Report Years Considered
Figure 11. Product Picture of Pre-Erythrocytic Vaccine
Figure 12. Product Picture of Erythrocytic Vaccine
Figure 13. Product Picture of Multi-antigen Vaccine
Figure 14. Global Malaria Vaccines Market Share by Type in 2022 & 2028
Figure 15. Global Malaria Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Malaria Vaccines Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Malaria Vaccines Sales by Type (2017-2028) & (K Units)
Figure 18. Global Malaria Vaccines Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Malaria Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 20. United States Malaria Vaccines Market Share by Type in 2022 & 2028
Figure 21. United States Malaria Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Malaria Vaccines Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Malaria Vaccines Sales by Type (2017-2028) & (K Units)
Figure 24. United States Malaria Vaccines Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Malaria Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 26. Product Picture of Hospitals
Figure 27. Product Picture of Clinics
Figure 28. Product Picture of Community Centers
Figure 29. Global Malaria Vaccines Market Share by Application in 2022 & 2028
Figure 30. Global Malaria Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
Figure 31. Global Malaria Vaccines Sales Market Share in Value by Application (2017-2028)
Figure 32. Global Malaria Vaccines Sales by Application (2017-2028) & (K Units)
Figure 33. Global Malaria Vaccines Sales Market Share in Volume by Application (2017-2028)
Figure 34. Global Malaria Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 35. United States Malaria Vaccines Market Share by Application in 2022 & 2028
Figure 36. United States Malaria Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. United States Malaria Vaccines Sales Market Share in Value by Application (2017-2028)
Figure 38. United States Malaria Vaccines Sales by Application (2017-2028) & (K Units)
Figure 39. United States Malaria Vaccines Sales Market Share in Volume by Application (2017-2028)
Figure 40. United States Malaria Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 41. North America Malaria Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 42. North America Malaria Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. U.S. Malaria Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada Malaria Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe Malaria Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 46. Europe Malaria Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany Malaria Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France Malaria Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. Malaria Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy Malaria Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia Malaria Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific Malaria Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 53. Asia-Pacific Malaria Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China Malaria Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan Malaria Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea Malaria Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India Malaria Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia Malaria Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Taiwan Malaria Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia Malaria Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand Malaria Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia Malaria Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Philippines Malaria Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America Malaria Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 65. Latin America Malaria Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico Malaria Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil Malaria Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina Malaria Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Middle East & Africa Malaria Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 70. Middle East & Africa Malaria Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Turkey Malaria Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Saudi Arabia Malaria Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. U.A.E Malaria Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Malaria Vaccines Value Chain
Figure 75. Malaria Vaccines Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
Industry Market Size
